B4699 - Muscle function in ALSPAC participants methodology descriptives and correlates - 09/11/2024

B number: 
B4699
Principal applicant name: 
Alex Ireland | Manchester Metropolitan University (United Kingdom)
Co-applicants: 
Prof Rachel Cooper, Prof Jon Tobias, Dr Snehal Pinto Pereira, Dr Ahmed Elhakeem
Title of project: 
Muscle function in ALSPAC participants: methodology, descriptives and correlates
Proposal summary: 

Muscle function is multi-dimensional, with different components of function such as power, balance, and fatigability relating to clinical and quality of life outcomes such as mobility, falls risk and the ability to carry out activities of daily living. Maintaining good muscle function across life is essential for overall health, mobility, and wellbeing. Previous research has largely focused on identifying factors that influence declines in muscle function in older adults. However, muscle function in later life is a consequence not only of declines experienced from midlife onwards but also of the peak achieved earlier in adulthood.

In addition, large population-based studies like ALSPAC have typically used simple measures of muscle function, which may not capture variance in important aspects including balance, power, mobility, and fatiguability.

In the recent ALSPAC@30 clinic, multiple detailed measures of different aspects of muscle function including power, balance and fatigability were ascertained, at scale, for the first time in young adults. We aim to combine these novel data with ALSPAC’s existing longitudinal information on exposures including physical activity (PA) and obesity. This provides a unique opportunity to identify and investigate important factors associated with the promotion of maximum peak muscle function.

In this project, we are particularly interested in looking at how PA, sedentary behaviour (SB) and body composition including obesity from birth onwards are associated with peak muscle function. Previous studies have shown that PA, SB, and body composition are important for muscle function in children and middle-aged and older adults, although we have limited understanding of their association with peak muscle function in young adults. We expect that the impact of these factors will be more pronounced in cohorts born from the 1990s onwards, including the ALSPAC cohort, because younger generations are much more likely to be inactive and obese than previous generations.

In addition, we can benefit from the fact that new technologies allow us to measure physical activity and obesity more accurately and in greater detail than ever before. There are several typical patterns of PA, SB and obesity change throughout childhood, adolescence and early adulthood, and so we are keen to find out if there are particular periods of development during these key life stages where differences in PA, SB or obesity have a greater influence on muscle function.

Impact of research: 
An initial characterisation of the detailed muscle function data collected in ALSPAC will provide details on its reliability and value in the context of a large population-based study. This will be a flagship study for all future work done in ALSPAC using the data. This work will highlight the value of the muscle function/health data in addition to providing information on their use and interpretation, thereby promoting their use by other researchers. Also, it will promote implementation and use of these measures in future data collections in ALSPAC and other studies. Understanding how and at which key life stages PA and SB trajectories influence components of muscle function and underlying quantity and quality will inform the development of more effective interventions and guidance to promote muscle health and function. This information will also allow us to identify groups of adults who may require more support to mitigate long-term muscle health deficits due to inactivity and obesity. This project is intended to provide a basis for developing behavioural interventions and public health messaging to optimise peak muscle health; long-term social, health and economic benefits will be achieved by reducing future sarcopenia risk and ultimately improving public health.
Date proposal received: 
Friday, 20 September, 2024
Date proposal approved: 
Saturday, 21 September, 2024
Keywords: 
Epidemiology, Sarcopenia, Assessment of physical function, musculoskeletal